These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8314491)

  • 1. Role of screening in prevention and treatment.
    Kane M; Alter M; Esteban R; Rizzetto M
    Gut; 1993; 34(2 Suppl):S45-7. PubMed ID: 8314491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfusion-transmitted hepatitis virus infection.
    Dodd RY
    Hematol Oncol Clin North Am; 1995 Feb; 9(1):137-54. PubMed ID: 7737938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance of alanine aminotransferase screening in blood donors for risk reduction of hepatitis B and C transmission by haemotherapy].
    Kusendová K; Gavorník P; Sabaka P; Sviteková K
    Vnitr Lek; 2016 Jan; 62(1):9-16. PubMed ID: 26967232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of donor selection in avoiding hepatitis virus transmission.
    Warson SI
    Scand J Haematol Suppl; 1984; 40():313-5. PubMed ID: 6433458
    [No Abstract]   [Full Text] [Related]  

  • 5. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
    Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
    Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance for acute viral hepatitis - United States, 2007.
    Daniels D; Grytdal S; Wasley A;
    MMWR Surveill Summ; 2009 May; 58(3):1-27. PubMed ID: 19478727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of individual-donation and minipool testing to detect low-level hepatitis B virus DNA in Taiwan.
    Yang MH; Li L; Hung YS; Hung CS; Allain JP; Lin KS; Tsai SJ
    Transfusion; 2010 Jan; 50(1):65-74. PubMed ID: 19709394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transfusion safety].
    Aprili G
    Haematologica; 1991 Jun; 76 Suppl 3():385-94. PubMed ID: 1752537
    [No Abstract]   [Full Text] [Related]  

  • 9. Screening of blood donors for non-A non-B hepatitis.
    Lancet; 1981 Jul; 2(8237):73. PubMed ID: 6113444
    [No Abstract]   [Full Text] [Related]  

  • 10. [Safe blood in the absence of viral infections due to HBV, HCV and HIV in serological window period in donors].
    Contreras AM; Reta CB; Torres O; Celis A; Domínguez J
    Salud Publica Mex; 2011; 53 Suppl 1():S13-8. PubMed ID: 21877067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of blood centers in the screening of blood donors for viral markers.
    Dogbe EE; Arthur F
    Pan Afr Med J; 2015; 20():119. PubMed ID: 26090067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings.
    Owusu-Ofori S; Temple J; Sarkodie F; Anokwa M; Candotti D; Allain JP
    Transfusion; 2005 Feb; 45(2):133-40. PubMed ID: 15660820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National strategy for the prevention and management of transfusion-associated hepatitis.
    Voigt MD; Bird AR; Kirsch RE; Kew MC; Aspinall S; Sims J
    S Afr Med J; 1996 Mar; 86(3):245-51. PubMed ID: 8658294
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative sensitivity of different solid-phase immunoassays for detecting HBsAg and anti-HCV in blood].
    León P; López JA; Domingo CJ; Echevarría JM
    Sangre (Barc); 1992 Oct; 37(5):407-10. PubMed ID: 1284096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral hepatitis in solid organ transplantation other than liver.
    Vallet-Pichard A; Fontaine H; Mallet V; Pol S
    J Hepatol; 2011 Aug; 55(2):474-82. PubMed ID: 21241754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on epidemiology of hepatitis B and C in China.
    Cui Y; Jia J
    J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():7-10. PubMed ID: 23855289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
    Busch MP
    Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of preventive applications on prevalence of hepatitis B virus and hepatitis C virus infections in West Turkey.
    Sakarya S; Oncu S; Ozturk B; Oncu S
    Saudi Med J; 2004 Aug; 25(8):1070-2. PubMed ID: 15322600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost effectiveness of adding nucleic acid testing to hepatitis B, hepatitis C, and human immunodeficiency virus screening of blood donations in Zimbabwe.
    Mafirakureva N; Mapako T; Khoza S; Emmanuel JC; Marowa L; Mvere D; Postma MJ; van Hulst M
    Transfusion; 2016 Dec; 56(12):3101-3111. PubMed ID: 27696441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transmission and prevention of viral hepatitis].
    Pascal JP
    Rev Prat; 1995 Jan; 45(2):174-9. PubMed ID: 7725018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.